Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Fluctuating illness charges, revolutionary therapies and discuss of “moonshots” within the White Home could make most cancers seem to be a contemporary scourge....
Medical trial affected person Dale Cousins, proper, stands with nuclear oncologist Dr. David Laidley after receiving a brand new prostate most cancers remedy...
